Market Place
Sourcing Support
Haryana FDA Detects 33 Overpricing Violations In 2025
08 Jan 2026 //
PHARMABIZ
Telangana DCA Unveils Crackdown On Interstate Fake Medicine
07 Jan 2026 //
PHARMABIZ
Wyoming Supreme Court Throws out Abortion Bans
06 Jan 2026 //
REUTERS
Haryana FDA Issues Directive On High-Risk Solvents Labelling
05 Jan 2026 //
PHARMABIZ
India Proposes Ban On OTC Syrup Sales Post Contamination Crisis
05 Jan 2026 //
RAPS
Haryana & Telangana Crack Down On Nimesulide Over 100 Mg
03 Jan 2026 //
PHARMABIZ
NPPA Awaits Recovery Of 85% Overcharged Amount
31 Dec 2025 //
PHARMABIZ
TN DCA Reveals 364 Safety Violations as Coldrif Survivor Returns
31 Dec 2025 //
PHARMABIZ
UK Regulator Warns of Risky Online Treatments
31 Dec 2025 //
INDPHARMAPOST
Government Bans Nimesulide Oral Formulations Above 100 mg
31 Dec 2025 //
ECONOMICTIMES
Corcept Gets Complete Response Letter For Relacorilant
31 Dec 2025 //
BUSINESSWIRE
Doctors Warn Against Antibiotic Misuse As Resistance Threat Grows
29 Dec 2025 //
ECONOMICTIMES
NPPA Permits Serum Institute To Halt Production Of 2 TT Vaccine
29 Dec 2025 //
PHARMABIZ
IIL Confirms Removal Of Counterfeit Abhayrab Rabies Vaccine
27 Dec 2025 //
ECONOMICTIMES
Drug Firms Extend GMP Compliance Time, States IDMA
27 Dec 2025 //
ECONOMICTIMES
Sun Pharma Arm Recalls 17K+ Antifungal Shampoos in US
25 Dec 2025 //
ECONOMICTIMES
Panel Urges Stringent Penalties For False Ayush Ads
24 Dec 2025 //
PHARMABIZ
CDSCO Reports 205 Samples As NSQ In November
23 Dec 2025 //
PHARMABIZ
TGA Seeks Feedback On Medicine Label Changes In Australia
22 Dec 2025 //
RAPS
Shape Memory Medical Obtains EU MDR Certification For IMPEDE
22 Dec 2025 //
BUSINESSWIRE
FDA Posts Warning Letters To Manufacturers Of Breast Binders
19 Dec 2025 //
RAPS
Minnesota Jury Awards $65.5M vs. Johnson & Johnson
19 Dec 2025 //
BUSINESSWIRE
BMS’ Cobenfy TV Ad Is Latest Target Of FDA Untitled Letter Spree
19 Dec 2025 //
FIERCE PHARMA
AZ To Pull Bleeding Reversal Agent After FDA Flags Risk Imbalance
19 Dec 2025 //
FIERCE PHARMA
FDA hit Catalent`s Maryland Manufacturing Sites with Form 483
19 Dec 2025 //
FIERCE PHARMA
FDA Cancels 13 Stores, Suspends 32 Intoxicant tablets Licenses
18 Dec 2025 //
ECONOMICTIMES
Health Ministry Drafts Amendments To MDR, 2017
18 Dec 2025 //
PHARMABIZ
FDA Issues `OAI` To Sun Pharma`s Baska facility After Inspection
18 Dec 2025 //
ECONOMICTIMES
FDA Issues Form 483 with 5 Observations to Aurobindo Unit
18 Dec 2025 //
ECONOMICTIMES
AKCDA Urges DCGI Action On Kerala Discount Pharmacies` Fake Drug
17 Dec 2025 //
PHARMABIZ
Novo Gets Warning Letter At Site Formerly Owned By Catalent
17 Dec 2025 //
FIERCE PHARMA
Trial By Fire: Over 60% Of Pharma SMEs May Be Forced To Shut Shop
16 Dec 2025 //
ECONOMICTIMES
US FDA sends warning letters to Walmart
15 Dec 2025 //
REUTERS
Himachal Drug Cos Under Stop Orders Found Operational
13 Dec 2025 //
ECONOMICTIMES
GAO Finds FDA Staffing Shortfalls Delaying Device Recall Work
12 Dec 2025 //
FIERCE BIOTECH
AICDF Seeks Pharma Prosecution for Decade-Long Non-Compliance
11 Dec 2025 //
PHARMABIZ
FDA Warns Companies For CGMP Violations, Unapproved Marketing
10 Dec 2025 //
RAPS
Merck, Sanofi, AZ Shots For RSV Now Under Scrutiny By FDA
09 Dec 2025 //
FIERCE PHARMA
India Pharma Inc Shifts From Compliance To Commitment In Safety
09 Dec 2025 //
EXPRESSPHARMA
Ipca Receives 3 Observations from FDA for API Facility
06 Dec 2025 //
INDPHARMAPOST
FDA Panel Votes Against J&J Shunt Implant For Heart Failure
05 Dec 2025 //
FIERCE BIOTECH
USFDA Issues Form 483 With 3 Observations To Ipca`s Tarapur Plant
05 Dec 2025 //
ECONOMICTIMES
Precipio Identifies Unauthorized Access to Isolated Storage
04 Dec 2025 //
GLOBENEWSWIRE
FDA Official: CDER Warning Letters Up 50% In FY 2025
04 Dec 2025 //
RAPS
DOJ, FDA Prosecutions Highlight HCG Sales Risks
04 Dec 2025 //
PR NEWSWIRE
Bihar IPA Criticizes Regulatory Failure As DEG Syrup Kills 23
04 Dec 2025 //
PHARMABIZ
FDA Letter To Daiichi Takes Aim At Turalio Patient Video
04 Dec 2025 //
FIERCE PHARMA
Indonesia Firm Executive Suspect in Radioactive Contamination
04 Dec 2025 //
REUTERS
CDSCO Issues Risk Classification For 187 Radiology Devices
02 Dec 2025 //
PHARMABIZ
Ethiopian Team Visits Telangana for Drug Regulation Study
28 Nov 2025 //
PHARMABIZ
Torrent Pharma Fined Rs 41 Crore Over Alleged Wrong GST Refund
28 Nov 2025 //
ECONOMICTIMES
FDA Grants VAI Status to Biocon`s Bengaluru Facility
27 Nov 2025 //
ECONOMICTIMES
CDSCO Bans High-Risk Solvents in Pediatric Oral Drugs
27 Nov 2025 //
BUSINESS STD
Glenmark Pharma Gets VAI From FDA For Monroe Facility
27 Nov 2025 //
INDPHARMAPOST
CDSCO Panel Calls For Consistent Drug Standard Enforcement
27 Nov 2025 //
BUSINESS STD
Telangana DCA Enforces CDSCO Mandate For Drug Safety Reporting
26 Nov 2025 //
PHARMABIZ
Sanofi Caught Up In Tax Fraud Probe Involving Several Companies
26 Nov 2025 //
FIERCE PHARMA
Haryana FDA Hosts Summit on Spurious Drugs, NDPS Fight
25 Nov 2025 //
PHARMABIZ
Abbott Urgently Corrects Freestyle Libre 3 Sensors Over Safety
25 Nov 2025 //
INDPHARMAPOST
Commenters Advocate For Clearer Safety Label Guidance
24 Nov 2025 //
RAPS
